Minerva

Low carb diets and other stories . . .

BMJ 2014; 348 doi: https://doi.org/10.1136/bmj.g3189 (Published 14 May 2014) Cite this as: BMJ 2014;348:g3189

Helping people with type 2 diabetes to lose weight is difficult work. But in a field bedevilled with surrogate outcomes, weight loss is one outcome that we can be pretty certain will benefit people in the long term. A randomised trial from California and Minnesota (Diabetes Care 2014, doi:10.2337/dc13-2900) adds to the growing evidence that the most successful diet is one that restricts carbohydrate rather than fat. In 227 adults with type 2 diabetes and a mean starting weight of 105.5 kg, relative weight loss was 7.4% (95% CI 5.7% to 9.2%), 9.0% (7.1% to 10.9%), and 2.5% (1.3% to 3.8%) for the lower fat, lower carbohydrate, and usual care groups.

Co-amoxifruse is the imaginary name of a drug combination often given to breathless older patients. Usually furosemide is given first. This was confirmed in a recent study from Ottawa, where paramedics have a medical directive to administer nitroglycerin and furosemide to any patient thought to …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe